Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 6/20 | 0.38 |
| ▸ | FAAH | O00519 | 3/20 | 0.35 |
| ▸ | MME | P08473 | 1/20 | 0.35 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.31 |
| ▸ | PKM | P14618 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.30 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2775300 | 0.84 | MGLL (0.38) | MGLLMMEHSP90AA1PKMNPSR1 | |
| SCHEMBL326688 | 0.80 | PKM (0.49) | MGLLFAAHDDAH1HSP90AA1PKM | |
| SCHEMBL2239737 | 0.74 | POLB (0.51) | MMEPKMTDP1L3MBTL1ALDH1A1 | |
| SCHEMBL8818955 | 0.73 | MME (0.42) | MMEMAPK1ALDH1A1HPGD | |
| SCHEMBL7199030 | 0.73 | MME (0.45) | MMEHSP90AA1MAPK1ALDH1A1MAPT | |
| SCHEMBL45163 | 0.72 | FAAH (0.39) | MGLLFAAHDDAH1HSP90AA1NPSR1 | |
| SCHEMBL5037159 | 0.72 | FAAH (0.39) | MGLLFAAHDDAH1HSP90AA1NPSR1 | |
| SCHEMBL859388 | 0.72 | MME (0.46) | MMEPKMALDH1A1 | |
| SCHEMBL2325576 | 0.71 | MME (0.40) | MMEMAPK1ALDH1A1HPGD | |
| SCHEMBL3622599 | 0.71 | MME (0.40) | MMEMAPK1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060105974-A1 | Conjugates of photosensitizers and oligonucleotides for selective photochemiotherapy | ECOLE POLYTECHNIQUE FEDERAL DE LAUSANNE (CH) | 2006-05-18 | — | — | US | disclosed |
| WO-2004004769-A1 | CONJUGATES OF PHOTOSENSITIZERS AND OLIGONUCLEOTIDES FOR SELECTIVE PHOTOCHEMIOTHERAPY | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2004-01-15 | — | — | WO | disclosed |
| US-20040002466-A1 | Targeted delivery of genes encoding interferon | THE IMMUNE RESPONSE CORPORATION | 2004-01-01 | — | — | US | disclosed |
| US-20030224508-A1 | Novel vectors and genes exhibiting increased expression | ILL CHARLES R (US) | 2003-12-04 | — | — | US | disclosed |
| US-6642028-B1 | Isolated DNA encoding a Factor VIII protein; consensus splice sites which have been corrected relative to those of given nucleotide sequence | THE IMMUNE RESPONSE CORPORATION | 2003-11-04 | — | — | US | disclosed |
| US-6331525-B1 | ADMINISTERING COMPLEX OF GENE RELEASABLE LINKED TO CONJUGATE OF CATIONIC AGENT WHICH BINDS LIGAND; LIGAND BINDS ASIALOGLYCOPROTEIN RECEPTOR ON HEPATOCYTE; TREATING HEPATITIS INFECTIONS | THE IMMUNE RESPONSE CORPORATION | 2001-12-18 | — | — | US | disclosed |
| US-6069133-A | TO A LIVER CELL USING COMPLEX OF THE GENE LINKED A SPECIFIC PROMOTER AND ENHANCER RELEASABLY LINKED TO A CONJUGATE OF A CATIONIC AGENT WHICH BINDS THE GENE AND A LIGAND WHICH BINDS TO THE ASIALOGLYCOPROTEIN RECEPTOR ON SURFACE OF LIVER CELLS | THE IMMUNE RESPONSE CORPORATION (US) | 2000-05-30 | — | — | US | disclosed |
| US-5994316-A | MIXING; COMPLEXING; CHARGE NEUTRALIZATION | THE IMMUNE RESPONSE CORPORATION (US) | 1999-11-30 | — | — | US | disclosed |
| WO-1999059643-A2 | LIPOSOMAL DELIVERY COMPLEX | SDG, INC. (US) | 1999-11-25 | — | — | WO | disclosed |
| WO-1999015687-A1 | MULTICOMPONENT POLYNUCLEOTIDE COMPLEX FOR HIGH EFFICIENCY CELL TRANSFECTION | UNIVERSITY OF CONNECTICUT (US) | 1999-04-01 | — | — | WO | disclosed |
| US-5843770-A | Antisense constructs directed against viral post-transcriptional regulatory sequences | THE IMMUNE RESPONSE CORPORATION (US) | 1998-12-01 | — | — | US | disclosed |
| US-5744326-A | VECTOR COMPRISING AN INTRONLESS GENE AND ONE OR MORE COPIES OF THE REGULATORY ELEMENT | THE IMMUNE RESPONSE CORPORATION (US) | 1998-04-28 | — | — | US | disclosed |
| US-5728518-A | SOLUBLE COMPLEX OF A POLY- OR OLIGONUCLEOTIDE AND A CARRIER | THE IMMUNE RESPONSE CORPORATION (US) | 1998-03-17 | — | — | US | disclosed |
| US-5728399-A | A SOLUBLE MOLECULAR COMPLEX COMPRISING A POLYNUCLEOTIDE, A CARRIER AND A BACTERIAL COMPONENT | UNIVERSITY OF CONN. (US) | 1998-03-17 | — | — | US | disclosed |
| EP-0804603-A1 | USE OF A BACTERIAL COMPONENT TO ENHANCE TARGETED DELIVERY OF POLYNUCLEOTIDES TO CELLS | TARGETECH, INC. (US) | 1997-11-05 | — | — | EP | disclosed |
| EP-0739415-A1 | ANTI-HEPATITIS B POLY- AND OLIGONUCLEOTIDES | TARGETECH, INC. (US) | 1996-10-30 | — | — | EP | disclosed |
| WO-1996000792-A1 | USE OF A BACTERIAL COMPONENT TO ENHANCE TARGETED DELIVERY OF POLYNUCLEOTIDES TO CELLS | UNIVERSITY OF CONNECTICUT (US) | 1996-01-11 | — | — | WO | disclosed |
| WO-1995019433-A2 | ANTI-HEPATITIS B POLY- AND OLIGONUCLEOTIDES | TARGETECH, INC. (US) | 1995-07-20 | — | — | WO | disclosed |